Detection of ACCPA Levels in Patients with Proteus Mirabilis Urinary Tract Infection: Possible Implications for Rheumatoid Arthritis
Abstract
Objective: To investigate the anti-citrullinated protein antibodies (ACCPA) value for patients who have urinary tract infection (UTI) with Proteus mirabilis (P. mirabilis) and rheumatoid arthritis (RA) patients. Methods: Eighty serum samples were analyzed for antibodies to cyclic citrullinated peptides (Anti-CCP) by ELISA. The samples included 40 from patients with RA diagnosed according to the 2010 American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) criteria, 20 from patients with UTI caused by P. mirabilis, and 20 from healthy controls. Results: ACCPA was significantly higher in RA patients (P
Fields of Study & Subjects
Rheumatoid Arthritis Research and Therapies
Gout
Hyperuricemia
Uric Acid
Systemic Lupus Erythematosus Research
Publication details
- Journal / source
- Journal of Contemporary Medical Sciences
- Volume
- 12
- Issue
- 1
- Publication date
- 26 February 2026
- Language
- EN